Wall Street Zen lowered shares of Phreesia (NYSE:PHR – Free Report) from a buy rating to a hold rating in a report released on Saturday morning,Wall Street Zen reports.
PHR has been the topic of several other research reports. Raymond James Financial lowered shares of Phreesia from an “outperform” rating to a “market perform” rating in a research report on Tuesday, September 8th. Royal Bank Of Canada reissued an “outperform” rating and set a $19.00 target price on shares of Phreesia in a research report on Thursday, September 3rd. Canaccord Genuity Group restated a “buy” rating and set a $16.00 price target on shares of Phreesia in a research note on Thursday, September 3rd. Citigroup restated a “market perform” rating on shares of Phreesia in a research note on Tuesday, October 20th. Finally, Weiss Ratings raised shares of Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a report on Monday, October 19th. Eight analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $14.07.
View Our Latest Research Report on Phreesia
Phreesia Price Performance
Phreesia stock opened at $12.62 on Friday. Phreesia has a 52 week low of $7.77 and a 52 week high of $23.87. The company’s 50 day moving average price is $10.99 and its two-hundred day moving average price is $11.11. The stock has a market cap of $783.14 million, a P/E ratio of 42.33 and a beta of 0.84. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.33.
Phreesia (NYSE:PHR – Get Free Report) last released its earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.06). Phreesia had a net margin of 2.06% and a return on equity of 5.22%. The business had revenue of $129.46 million during the quarter, compared to the consensus estimate of $129.06 million. During the same period in the prior year, the company earned $0.01 earnings per share. The business’s revenue was up 10.4% on a year-over-year basis. On average, equities analysts predict that Phreesia will post 0.33 earnings per share for the current year.
Insider Buying and Selling
In other Phreesia news, General Counsel Allison C. Hoffman sold 6,662 shares of the stock in a transaction dated Monday, September 21st. The shares were sold at an average price of $10.08, for a total transaction of $67,152.96. Following the completion of the transaction, the general counsel owned 266,574 shares in the company, valued at $2,687,065.92. This trade represents a 2.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 5.20% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Phreesia
Several large investors have recently modified their holdings of the business. Sterling Capital Management LLC boosted its holdings in Phreesia by 4.7% in the 3rd quarter. Sterling Capital Management LLC now owns 26,410 shares of the company’s stock worth $273,000 after buying an additional 1,190 shares during the period. State of Alaska Department of Revenue boosted its holdings in shares of Phreesia by 553.9% in the third quarter. State of Alaska Department of Revenue now owns 23,135 shares of the company’s stock worth $238,000 after acquiring an additional 19,597 shares during the period. N10 Wealth LLC bought a new position in shares of Phreesia in the third quarter worth $118,000. Sequoia Financial Advisors LLC purchased a new position in shares of Phreesia in the second quarter valued at $159,000. Finally, Integrated Wealth Concepts LLC grew its position in shares of Phreesia by 37.2% in the second quarter. Integrated Wealth Concepts LLC now owns 14,129 shares of the company’s stock valued at $145,000 after purchasing an additional 3,834 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.
About Phreesia
Phreesia, Inc is a healthcare technology company that provides a platform for managing administrative and financial interactions between healthcare organizations and their patients. Its software is designed to help medical practices and other care providers streamline registration, intake, payments, communications and related workflows.
The Phreesia platform includes digital patient check-in tools that allow patients to complete forms, update demographic and insurance information, make payments and review relevant educational or administrative content.
Further Reading
- Five stocks we like better than Phreesia
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.
